Disc Medicine (IRON) Capital Expenditures (2021 - 2025)
Disc Medicine's (IRON) quarterly Capital Expenditures came in at $20000.0 in Q4 2025, down 95.55% year-on-year from $449000.0 in Q4 2024, and down 23.08% on a QoQ basis from $26000.0 in Q3 2025.
Disc Medicine (IRON) Capital Expenditures (2021 - 2025) Analysis & Trends
Disc Medicine (IRON) has 5 years of Capital Expenditures data on file, last reported at $20000.0 in Q4 2025.
- On a quarterly basis, Capital Expenditures fell 95.55% year-over-year to $20000.0 in Q4 2025; TTM through Mar 2026 was $82000.0, a 93.64% decrease from a year earlier, with the FY2025 full-year figure at $933000.0, up 84.75% from the prior year.
- Capital Expenditures for Q4 2025 stood at $20000.0, down from $26000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for IRON reached as high as $851000.0 in Q1 2025 and fell as low as -$8000.0 in Q3 2024.
- Historically, Capital Expenditures has averaged $99117.6 across 5 years, with a median of $20000.0 in 2025.
- On a YoY basis, Capital Expenditures climbed as much as 14866.67% in 2024 and fell as far as 125.0% in 2024.
- Year by year, Capital Expenditures stood at $7000.0 in 2021, then surged by 71.43% to $12000.0 in 2022, then slumped by 75.0% to $3000.0 in 2023, then soared by 14866.67% to $449000.0 in 2024, then slumped by 95.55% to $20000.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $20000.0 in Q4 2025, $26000.0 in Q3 2025, and $36000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 851,000.00 |
| Mar 31, 2025 | 851,000.00 |
| Dec 31, 2024 | 449,000.00 |
| Dec 31, 2024 | 449,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Sep 30, 2023 | 45,000.00 |